InspireMD, Inc. (NSPR) stock forecast and price target
Price $0.64 · data as of November 13, 2026
12-month price target
Average target$3.33
Upside / downside+417.5%
Analysts3
ConsensusBuy
Low $3.00Average $3.33High $4.00
Gold marker: average target · white marker: today’s price ($0.64)
Analyst ratings
Strong buy 2Buy 1Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.44 | +42.1% | $10M |
| Next fiscal year ends December 31, 2027 | $-0.48 | −8.3% | $17M |
| Next quarter ends December 31, 2026 | $-0.11 | +21.4% | $3M |
| Quarter after ends March 31, 2027 | $-0.12 | +21.9% | $3M |
Consensus of the analysts covering InspireMD, updated daily. In the last 30 days 2 estimates were raised and 0 lowered.
Frequently asked questions
What is the InspireMD stock price target?
The average 12-month target from 3 analysts is $3.33, 417.5% above the current price of $0.64 Targets range from $3.00 to $4.00.
Is InspireMD a buy according to analysts?
The consensus rating is “Buy” (2 strong buy, 1 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is InspireMD expected to earn?
Analysts expect EPS of $-0.44 for the fiscal year ending December 31, 2026 and $-0.48 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.